Three Hot Topics from ADA 2024

Three Hot Topics from ADA 2024

Biotech takes on chronic weight management As Novo Nordisk and Lilly generate massive profits with weight-loss blockbusters Wegovy and Zepbound, several smaller players are looking to develop novel solutions that address some of the challenges with currently marketed...